1. N. Sarwar et al., Emerging Risk Factors Collaboration. (2010). Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. The Lancet, 375(9733), 2215-2222.
2. Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G. A., et. al. (2007). Clinical end points in coronary stent trials: a case for standardized definitions. Circulation, 115(17), 2344-2351.
3. Sanchez, O. D., Sakakura, K., Otsuka, F., Yahagi, K., Virmani, R., & Joner, M. (2014) Coronary stent evolutıon–from pathology to clınıc. EMJ Int. Cardiol., 107–116.
4. Halwani, D. O., Anderson, P. G., Lemons, J. E., Jordan, W. D., Anayiotos, A. S., & Brott, B. C. (2010). In-vivo corrosion and local release of metallic ions from vascular stents into surrounding tissue. Journal of Invasive Cardiology, 22(11), 528-535.
5. Iqbal, J., Gunn, J., & Serruys, P. W. (2013). Coronary stents: historical development, current status and future directions. British medical bulletin, 106(1), 193-211.